He left a Top 100 law firm to do something stranger: teach a computer to see every muscle in your body.
Muscle is the largest organ system in the body, and for most of medical history it has been measured the way you'd guess the weight of a pumpkin at a county fair - by squinting. A radiologist eyeballs an MRI. A trainer pinches a fold of skin. A scale spits out a single, blunt number. Scott Magargee runs the company arguing that this is absurd, and that there is a better way: turn the scan into data, and let the data speak for itself.
Magargee is the CEO and co-founder of Springbok Analytics, a Charlottesville, Virginia company that takes an ordinary MRI and returns something no human reader can produce by hand - a precise, 3D analysis of every individual muscle, its size, its left-right asymmetry, the fat quietly infiltrating it. The technology is FDA-cleared. It was born from more than fifteen years of research at the University of Virginia. And the pitch is disarmingly simple: muscle should be measured, not estimated.
What makes the story odd is the resume behind it. Magargee did not arrive from a biomechanics PhD program. He holds an AB in history from Princeton and a JD from the University of Richmond. He spent the early part of his career as a partner at a Top 100 Philadelphia law firm, handling government investigations, civil and criminal litigation, and regulatory matters. Somewhere between cross-examinations and case files, he co-founded the American Energy Society. Then he found health tech - business development at Metis Genetics, a senior vice president seat at Locus Health - and in December 2019 he took the wheel at a muscle-imaging startup spun out of a university engineering lab.
It is a strange path to muscle. It is also, on reflection, a useful one. Selling a brand-new category of medical software means convincing skeptical clinicians, regulators, investors, and pro sports teams all at once. A former litigator who can build a case tends to be good at exactly that.
The January 2025 round was led by Transition Equity Partners and oversubscribed, with the National Basketball Association among the backers - alongside Cartan Capital, TitletownTech, Getty Performance Science, CAV Angels and Alumni Ventures. When a sports league invests in your imaging math, the use case is obvious.
Unrivaled, the new women's pro basketball venture, had Springbok scan all 36 of its athletes ahead of the Miami debut. Repeat scans showed both the training gains and the quiet toll a season takes on a body - the kind of before-and-after that used to be invisible.
Springbok's muscle analysis has been folded into drug development, including a first-in-human study with Epicrispr Biotechnologies and a multi-site pediatric study in FSHD muscular dystrophy. Precise muscle measurement becomes a clinical-trial endpoint.
Magargee recruited human-performance scientist Dr. Andy Galpin to the advisory board. "His experience, credentials and reputation speak for themselves," he said - a tidy way of borrowing scientific gravity for a young category.
Springbok grew out of an interdisciplinary team at the University of Virginia, with co-founder and Chief Scientific Officer Silvia Blemker, a UVA biomedical engineering professor, supplying the science. The UVA Licensing & Ventures Group helped spin it into a company.
The stated goal isn't a niche tool for elite athletes. It's to make muscle health a routine, measurable part of medicine and longevity - the way blood panels and bone density already are.
"Our singular goal is to give people insight that was previously unavailable and organize it in easily digestible ways."
"This investment positions Springbok to become the global leader in precision muscle health analytics."
"We remain committed to delivering innovative solutions that empower patients, providers, and researchers in the attainment of precision medicine."
"We are honored that Dr. Galpin is joining our advisory board and committing his knowledge to furthering our positive impact on the human condition."
A Princeton history degree and a Richmond law degree. Neither one obviously ends at "muscle AI company," which is part of the charm.
One of his investors is the NBA. Most founders never get a major sports league on the cap table.
The company is named Springbok - the African antelope famous for explosive, springloaded muscle. The branding does the talking.
He sits on the board of Friends of FSH Research, which funds work on facioscapulohumeral muscular dystrophy.
Before muscles, he co-founded an energy-policy association. The through-line is less "topic" than "build the institution."